Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2024-07-02 00:00:00 ET · period of report 2024-06-28 · accession 0001437749-24-022006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-02 | 2024-06-28 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | A - Grant | $1.39 | +139 | 22.1K | +0.6% | +$193.21 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-28 | A | A | 139 | $1.39 | 22,073 | D | — | — | (F2) All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023. Holdings do not include options to purchase 348 shares. |